Microbial Caprolactone Production via Metabolic Pathway Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for effective methods to produce caprolactone, a precursor to specialized polymers, due to its high resistance to hydrolysis and excellent mechanical properties, but existing methods are inefficient.
Innovation Solution
Design and production of non-naturally occurring microbial organisms with caprolactone pathways by introducing nucleic acids encoding caprolactone pathway enzymes, allowing for biosynthetic production of caprolactone through metabolic engineering and adaptive evolution.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional chemical oxidation methods are used to produce caprolactone, then production efficiency is limited, but the process is straightforward and well-established
Solution Approach 1:
The caprolactone biosynthetic pathway is divided into multiple enzymatic steps, each catalyzed by a specific enzyme (adipyl-CoA reductase, adipate semialdehyde reductase, 6-hydroxyhexanoyl-CoA transferase/synthetase, 6-hydroxyhexanoyl-CoA cyclase). This segmentation allows for modular genetic engineering and optimization of individual pathway steps to improve overall productivity.
Solution Approach 2:
The patent introduces intermediary metabolic compounds (adipyl-CoA, adipate semialdehyde, 6-hydroxyhexanoyl-CoA) as substrates and products of sequential enzymatic reactions. These intermediaries serve as metabolic bridges that convert glucose to caprolactone through a series of controlled biochemical transformations, enabling efficient biosynthetic production.
2Adaptability or versatility
If biosynthetic pathways are introduced into microorganisms, then caprolactone production capability is achieved, but genetic stability must be maintained
Solution Approach 1:
Multiple genes encoding caprolactone pathway enzymes are combined into integrated biosynthetic pathways within the microorganism. The patent describes merging separate enzymatic functions into coordinated metabolic routes, allowing the organism to produce caprolactone while maintaining genetic stability through proper pathway integration and regulation.
Solution Approach 2:
The biosynthetic pathway incorporates feedback mechanisms where metabolic intermediates and end-products regulate enzyme activity and gene expression. This feedback control ensures stable production of caprolactone while preventing metabolic imbalances, maintaining both adaptability and genetic composition stability.
3Productivity
If CO2 fixation pathways are implemented, then product yield is enhanced, but metabolic pathway complexity increases
Solution Approach 1:
The patent implements preliminary CO2 fixation through the reductive TCA cycle before caprolactone synthesis. By fixing CO2 early in the metabolic pathway to generate precursors (oxaloacetate, malate), the system enhances carbon efficiency and product yield while organizing complexity in a logical sequence that facilitates metabolic flux toward caprolactone production.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach enables genetically stable microbial organisms capable of continuous bioprocesses, achieving a maximum theoretical yield of caprolactone from glucose and enhancing product yields by fixing CO2 through pathways like the reductive TCA cycle.
Implementation Method 1
enhancing product yields by fixing CO2 through pathways like the reductive TCA cycle
Data Source
AI summary
The invention provides non-naturally occurring microbial organisms containing caprolactone pathways having at least one exogenous nucleic acid encoding a butadiene pathway enzyme expressed in a sufficient amount to produce caprolactone. The invention additionally provides methods of using such microbial organisms to produce caprolactone by culturing a non-naturally occurring microbial organism containing caprolactone pathways as described herein under conditions and for a sufficient period of time to produce caprolactone.